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Abstract
Background: Identifying relatedness among diseases could help deepen understanding for the underlying
pathogenic mechanisms of diseases, and facilitate drug repositioning projects. A number of methods for
computing disease similarity had been developed; however, none of them were designed to utilize information of
the entire protein interaction network, using instead only those interactions involving disease causing genes. Most
of previously published methods required gene-disease association data, unfortunately, many diseases still have
very few or no associated genes, which impeded broad adoption of those methods. In this study, we propose a
new method (MedNetSim) for computing disease similarity by integrating medical literature and protein interaction
network. MedNetSim consists of a network-based method (NetSim), which employs the entire protein interaction
network, and a MEDLINE-based method (MedSim), which computes disease similarity by mining the biomedical
literature.
Results: Among function-based methods, NetSim achieved the best performance. Its average AUC (area under the
receiver operating characteristic curve) reached 95.2 %. MedSim, whose performance was even comparable to
some function-based methods, acquired the highest average AUC in all semantic-based methods. Integration of
MedSim and NetSim (MedNetSim) further improved the average AUC to 96.4 %. We further studied the
effectiveness of different data sources. It was found that quality of protein interaction data was more important
than its volume. On the contrary, higher volume of gene-disease association data was more beneficial, even with a
lower reliability. Utilizing higher volume of disease-related gene data further improved the average AUC of
MedNetSim and NetSim to 97.5 % and 96.7 %, respectively.
Conclusions: Integrating biomedical literature and protein interaction network can be an effective way to compute
disease similarity. Lacking sufficient disease-related gene data, literature-based methods such as MedSim can be
a great addition to function-based algorithms. It may be beneficial to steer more resources torward studying
gene-disease associations and improving the quality of protein interaction data. Disease similarities can be computed
using the proposed methods at http://www.digintelli.com:8000/.
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Background
Discovering closely related diseases could be helpful in
revealing their common pathophysiology [1, 2]. It may
also be useful for identifying novel drug indications [3],
as similar diseases may have the same or similar thera-
peutic targets, which suggests they could be treated with
the same or similar drugs. There has been a growing
interest in quantitatively measuring similarities between
diseases [4–7].
Phenotypic similarity plays an important role in a
number of biological and biomedical applications [8].
During the past years, based on the Human Phenotype
Ontology (HPO) [9], researchers had designed several
methods to find related diseases and predict disease-
causing genes, such as Phenomizer [10], Exomiser [11]
and PhenIX [12]. The HPO provides a controlled and
standardized vocabulary of phenotypic abnormalities
that characterize human diseases. Phenotype similarity
also, becomes the most common way to define classifi-
cation rules for diseases. The classification of disease
terms in Medical Subject Headings (MeSH) [13] and
Disease Ontology (DO) [14] are taking this approach. To
quantify disease similarity, several semantic-based
methods had thus been proposed based on HPO, MeSH
or DO, such as Resnik [15], Lin [16] and Wang [17].
Resnik’s method measures disease similarity based on in-
formation content (IC) of the most informative common
ancestor (MICA) between two terms. Besides IC of
MICA, Lin’s method also considers the IC of the two
compared diseases [16]. Wang et al.’s method [17] com-
putes similarity of a disease pair by considering the con-
tribution of all common ancestors in the ontology. It
had been successfully applied to compute similarity be-
tween MeSH [18] terms. All of those semantic-based
methods exploited disease associations based on ontol-
ogies and/or gene annotations. They did not, however,
consider the functional associations between disease-
related gene sets. The BOG (based on overlapping gene
sets) method was thus designed by Mathur and Dinakar-
pandian [19], which calculates disease similarity by
exploiting the co-occurrence of disease-related genes.
Mathur et al. [20] also devised a process-similarity based
(PSB) method. Instead of defining disease similarity as a
function of genes, PSB computes disease similarity based
on Gene Ontology (GO) [21] biological process terms
associated with those genes. PSB achieved a better
performance than BOG [20]. Functional associations be-
tween genes involve not only GO terms [22], but also
co-expression [23], protein-protein interaction [24], etc.
Cheng et al. recently presented the method FunSim [25],
which measures disease similarity using a weighted hu-
man protein interaction network. The first neighbors of
disease-related genes in the protein network were taken
into account. FunSim further improved the results of
PSB [25].
Although a number of methods for computing disease
similarity had been developed, no method had been pro-
posed to take advantage of the entire protein interaction
network, beyond using only the first neighbors. A
network-based method (NetSim) is proposed which
takes advantage of the entire interaction network. The
effectiveness of different data sources were also evalu-
ated, including gene-disease associations and protein-
protein interactions. Most of the previously developed
methods were based on disease-related genes. However,
many diseases still have very few or no associated genes.
Relying entirely on disease-related genes greatly limits
the utility of those methods. To overcome the limitation,
a new semantic-based similarity measure (MedSim) is
developed to compute disease similarity based on the
MEDLINE database. MedSim and NetSim were eventu-
ally integrated into MedNetSim to further improve com-
puting performance.
Methods
Diseases and gene-disease association databases
The disease terms in DO were chosen as the vocabulary
for describing diseases. DO database is a biomedical re-
source of disease concepts with stable identifiers orga-
nized by disease etiology [14]. It contains 6,457 non-
obsolete disease terms and 6,819 ‘IS_A’ relationships
among diseases. The non-obsolete disease terms was
used as the disease vocabulary. Each disease in DO has a
unique identifier, called DOID.
SIDD [26] and DisGeNET [27] were adopted as two
disease-gene association databases (Fig. 1). SIDD inte-
grated five disease-related gene databases: GeneRIF [28],
Online Mendelian Inheritance in Man (OMIM) [29],
Comparative Toxicogenomics Database (CTD) [30],
Genetic Association Database (GAD) [31], and SpliceDi-
sease [32]. In total, SIDD contains 2,427 diseases and
104,052 gene-disease associations (see Additional file 1).
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The DisGeNET [27] database integrated human gene-
disease associations from various expert curated databases
and text-mining derived associations including Mendelian,
complex and environmental diseases. Compared to SIDD,
DisGeNET had more lower reliability disease-gene associ-
ations based on literature mining, i.e., LHGDN [33] and
BeFree data [34]. DisGeNET contains 14,619 diseases and
429,111 gene-disease associations. UMLS ID (Unified
Medical Language System Identifier) was used as the
unique identifier for each disease in DisGeNET. We
mapped UMLS ID to DOID, which produced 3,259 dis-
ease terms and 206,403 gene-disease associations (see
Additional file 2). Almost every disease term in DisGeNET
has more associated genes than that in SIDD. All source
data were downloaded until April 30, 2015.
Protein interaction datasets
Two protein interaction datasets were used (Fig. 2). One
is hPPIN, built in house, which integrated four existing
protein interaction databases, i.e., BioGrid [35], HPRD
[36], IntAct [37], and HomoMINT [38]. Protein identi-
fiers were mapped to the genes coding for the proteins,
and redundant interactions were removed. The acquired
protein interaction network covered 15,710 human
genes and 143,237 interactions (Fig. 2). The other is
HumanNet [39], which is a genome-scale functional net-
work for human genes. To build HumanNet, 21 diverse
functional genomics and proteomics datasets were eval-
uated for their tendencies to link human genes in the
same biological processes. Pairwise gene linkages derived
from the individual datasets were then integrated into a
comprehensive HumanNet [39]. HumanNet contains
476,399 functional linkages among 16,243 human genes
(Fig. 2). Unlike hPPIN which mainly focuses on experi-
mentally verified protein interactions, HumanNet was
constructed based on the functional probability that two
genes belonged to the same biological processes. The
two protein interaction datasets have 13,626 genes and
42,584 interactions in common (called comPPI, Fig. 2).
Additionally, different proportions of hPPIN (5 %, 10 %,
20 %, 40 %, 60 %, 80 %, 90 %) were randomly sampled 20
times and used as the protein interaction datasets to evau-
late the impact of data volume on the proposed method.
Medline-based disease similarity (MedSim)
Biomedical literature contains rich and diverse informa-
tion, such as disease symptoms, pathogenesis, thera-
peutic drugs, and so on. Features representing diseases
were generated through mining the biomedical literature
corpus; the features were then utilized to compute
disease similarity (MedSim method, Fig. 3). MedSim was
not limited to use only one aspect of disease information
(i.e., disease-related genes), but took advantages of all
relevant information that had already been archived in
the literature.
Disease corpus
The text corpus contains all MEDLINE abstracts pub-
lished up to year 2015. The non-obsolete disease terms
in DO were used as the disease vocabulary. Each disease
Fig 1 Gene-disease association databases. a : The number of
diseases, b: The number of associations between genes and diseases
Fig 2 Protein interaction datasets. a: The number of genes, b: The
number of interactions between genes, *: The common
protein-protein interactions
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term was mapped to Unified Medical Language System
(UMLS) [40] so that its synonyms could be retrieved. Syn-
onyms were taken directly from DO for diseases that
could not be mapped to UMLS. Every disease term and its
synonyms were then used as keywords to perform
keyword-based queries into MEDLINE to retrieve ab-
stracts related to that disease. To limit computational cost,
only the top 100 most relevant abstracts were selected to
construct the bag-of-words model for diseases. The rele-





Where Wdf and Wof represent document frequency
and occurrence frequency of a word X, respectively.
Document frequency Wdf is the proportion of abstracts
that contain word X. Wdf represents the relevance of
word X to a disease. Occurrence frequency Wof repre-
sents the number of times word X occurs in an abstract,
measuring the importance of word X in a specific ab-
stract. For a specific disease, W is defined as the set of
nouns (Xs) which appeared in abstracts when Wdf is
greater than 0.005. Larger Rabstract means that an ab-
stract is more closely related to the disease. Some dis-
eases were not yet broadly studied, so their number of
retrieved abstracts can be less than 100. For those cases,
all retrieved abstracts were used. For each disease, the
selected most relevant abstracts were merged into one
combined document. At the end of preprocessing, every
disease was associated with one document. These docu-
ments together made up the disease corpus.
Constructing the bag-of-words model and computing
MedSim
The disease corpus was tokenized to obtain word vo-
cabulary, using Python package NLTK (Nature Language
Toolkit, www.nltk.org) to remove non-alphabetic words
and reduce inflected/derived words to their stem. Overly
common (appeared in more than 60 % of the docu-
ments) or rare (appeared in less than 4 documents)
words were removed, as those words could not provide
meaningful information. Each disease was then repre-
sented by a word vector, whose dimensionality is the size
of the word vocabulary. Each dimension was assigned a
weight (TF-IDF, that is, TF times IDF) based on term fre-
quency (TF) and inverse document frequency (IDF)
values. TF is the number of times a word appears in a
document. IDF represents the inverse of the number of
documents containing the word. TF-IDF assigns larger
weights to words that appeared more often in a document
but only in a small percentage of all documents, as those
words are important and informative for that document.
With diseases represented as TF-IDF weighted vectors,
the MedSim of two diseases was measured by calculating
the cosine similarity of the two vectors. Python package
scikit-learn [41] was used to perform the computation.
Network-based disease similarity (NetSim)
Previously published methods weren’t designed to utilize
the entire protein interaction network. They instead fo-
cused only on the disease-related genes or their first
neighbors in the network. To take full advantage of the
entire protein interaction network, random walk with re-
start (RWR) [42, 43] (see [44] for working details) was
used to measure Functional Relevance (FR) between a
gene g and a gene set G, which is described in Eq. 2.
FRGðgÞ ¼
PRWR g ∈ protein interaction network
1 g ∉ protein interaction network and g∈G
0 g ∉ protein interaction network and g∉GÞ8>><>:
ð2Þ
Fig 3 Overview of MedSim. DO: Human Disease Ontology database; UMLS: Unified Medical Language System
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Where gene set G was defined to be the seed genes,
that is, the known set of genes associated with a disease.
The initial probability of each seed genes was set to 1.0.
PRWR represents the acquired steady-state probability of
gene g after running RWR in the whole protein inter-
action network. A larger probability (FRG(g)) will be
assigned to gene g when it sits more closely to the gene
set G in the network according to Eq. 2, which means that
gene g are more functionally related with gene set G.
Suppose that G1 = {g11,g12,…} and G2 = {g21,g22,…} are
the seed gene sets for disease d1 and d2, respectively.
Then, the NetSim of d1 and d2 is defined in Eq. 3.









len G1ð Þþlen G2ð Þ ;
g1i∈G1; g2j∈G2
ð3Þ
Where len(G1) and len(G2) are the number of genes in
G1 and G2, respectively. The numerator is the sum of func-
tional relevance of g1i to G2 and g2j to G1. A higher NetSim
value represents closer connection between G1 and G2,
which suggests closer ties between diseases d1 and d2.
MedSim and NetSim is combined into MedNetSim,
which is defined in Eq. 4.
MedNetSim d1; d2ð Þ ¼ MedSim d1; d2ð Þ
 NetSim G1;G2ð Þ ð4Þ
Where d1 and d2 are two diseases in DO, G1 and G2
are the seed gene sets for d1 and d2, respectively.
Performance evaluation
Similarities of disease pairs in the benchmark set and
the random set were calculated and ranked in descend-
ing order, receiver operating characteristic (ROC) [45]
curves were then drawn to evaluate and quantify the
predictive power of the proposed methods. A ROC
curve is a plot of the true positive rate of a classifier as a
function of the false positive rate. The area under the
ROC curve (AUC) is used as a quantitative measure of a
classifier’s quality [46]. Disease pairs in the benchmark
set and the random set are defined as positives and neg-
atives, respectively. True positives are the disease pairs
in the benchmark set that are correctly predicted by a
classifier, and false positives are those disease pairs from
the random set that are predicted to be positives but not
found in the benchmark set. More percentage of disease
pairs in the benchmark set receiving higher rankings
means better AUC values. The benchmark set was taken
from reference [25]. It had 47 diseases and 70 disease
pairs (see Additional file 3) with high similarity derived
from two manually checked datasets by Suthram et al.
[2] and Pakhomov et al. [47]. Cancers were omitted. The
benchmark set contains disease pairs that are expected
to be related to each other, such as Alzheimer’s disease
(DOID: 10652) and schizophrenia (DOID: 5419), dia-
betes mellitus (DOID: 9351) and obesity (DOID: 9970).
It also includes some pairs that are not apparently re-
lated, but were found to be correlated by various evi-
dences, such as asthma (DOID: 2841) and diabetes
mellitus, malaria (DOID: 12365) and anemia (DOID:
2355). 700 disease pairs were randomly selected from
DO to generate a random set, with disease pairs from the
benchmark set removed from the generated random set.
To get an average AUC of the proposed methods, the above
experiment was iterated 50 times by calculating similarities
of disease pairs in the benchmark set and 50 random sets.
MedSim was compared with other semantic-based
methods including Resnik [15], Lin [16] and Wang [17],
based on HPO and DO, respectively. For each disease,
the associated HPO annotations were acquired from
[48], which covered disease-phenotype associations for
over 6000 common, rare, infectious and Mendelian dis-
eases through text-mining approach. The HPO-based
disease similarities were defined by calculating the se-
mantic similarity of their associated HPO phenotypes.
For two diseases (d1, d2), the HPO-based similarity of d1
to d2 is defined as follows:
HPO sim d1→d2ð Þ ¼ avg
X
s∈d1






Where s and t are the annotated phenotypes of d1 and
d2, respectively. SemSim() is one of the methods applied to
compute the semantic similarity of two phenotype terms,
including Resnik, Lin and Wang. Eq. 5, for each pheno-
type term of d1, found the “best match” among the pheno-
type terms annotated to d2, and the average overall
phenotype terms was calculated. Note that this similarity
is asymmetric, i.e., HPO_sim(d1→ d2) is not always equal
to HPO_sim(d2→ d1). Therefore, we used a symmetric
HPO-based similarity, which is defined in Eq. 6:
HPO sim d1; d2ð Þ ¼ 12HPO sim d1→d2ð Þ
þ 1
2
HPO sim d2→d1ð Þ ð6Þ
The DO-based disease similarities were defined as the
directly semantic similarity of two disease terms in DO,
where the above mentioned three semantic-base
methods (Resnik, Lin and Wang) were applied, too. Net-
Sim was also compared with other function-based
methods including BOG [19], PSB [20] and FunSim [25].
Parameters of the aforementioned methods were set to
values used in the original paper.
Li et al. BMC Bioinformatics  (2016) 17:326 Page 5 of 13
Constructing disease similarity network (DSN)
Disease terms from DO were used as nodes in the simi-
larity network between diseases (DSN). We computed
the pair-wise similarity for a total of 3,201 diseases (with
both associated genes and literature information) by the
proposed method MedNetSim. If the similarity of a dis-
ease pair was ranked in the top 0.5 %, an undirected
weighted edge between the disease pair was drawn. The
network was visualized with the force-directed layout al-
gorithm of Cytoscape [49] and colored according to top-
level DO categories.
Results and discussion
Utilizing the entire network benefits disease similarity
computation
Similarities of disease pairs in the benchmark set and a
random set were calculated by NetSim and other
function-based methods. As shown in Fig. 4a, the BOG
method, with an AUC of 83.3 %, had the worst perform-
ance among function-based methods. Linking genes
based on the GO biological process ontology [21], PSB
method had significantly improved performance, achiev-
ing an AUC of 91.1 %. Considering nearest neighbors of
disease-related genes in protein interaction network,
FunSim improved its AUC to 94.3 %. The proposed
method, NetSim, which utilized the entire protein inter-
action network, further improved its AUC to 95.1 %.
The results show that utilizing the entire network can
increase computing performance for disease similarity
calculation. Integrating MedSim (see next section) and
NetSim, the MedNetSim achieved the highest AUC
among all function-based methods, improving its AUC
to 96.5 %. The performance improvement indicates that
integration of MEDLINE and protein interaction net-
work can be an effective way to compute disease similar-
ities. To check the stability of NetSim and MedNetSim,
the above computation was repeated 50 times by calcu-
lating similarities using 50 randomly generated disease
pair sets. Fig 4b shows the average AUC of BOG
(82.6 %), PSB (90.9 %), FunSim (94.4 %), NetSim
(95.2 %) and MedNetSim (96.4 %), which is consistent
with Fig. 4a.
The MedNetSim similarity values of all disease pairs
were computed, and a distribution of 5,121,600 similar-
ity values (between 3,201 diseases) was acquired. The
ranking of a similarity value in the distribution was used
to compute its corresponding p-value. If the MedNetSim
similarity value of a disease pair is in the highest-ranking
5 % of the distribution (which generates a p-value of
0.05), the two diseases are considered related. To evalu-
ate the ability of MedNetSim in discriminating positive
and negative cases, the p-values of similarities of disease
pairs in the benchmark set and a random set were calcu-
lated (Additional file 4). For the benchmark set, 57 dis-
ease pairs were recognized as highly related diseases
correctly and 13 disease pairs did not show a significant
p-values (false negatives). The false negatives can be di-
vided into two groups. The first group had a non-
Fig 4 Performance of function-based methods. a ROC curves for the benchmark set and a random set. b Average AUC for the benchmark set
and 50 random sets
Li et al. BMC Bioinformatics  (2016) 17:326 Page 6 of 13
significant p-value of MedSim similarity, but a signifi-
cant p-value of NetSim similarity, e.g., polycystic ovary
syndrome (DOID: 11612) & myocardial infarction
(DOID: 5844), malaria (DOID: 12365) & epilepsy syn-
drome (DOID: 1826) (Table 1). The missed calling of be-
ing positives for those disease pairs was mainly due to
the very bad results of MedSim. That is to say, the re-
search literature contains less information about their
relatedness, therefore dragging down the performance of
MedNetSim. For those disease pairs, NetSim may be a
better choice. In the second group, both MedSim and
NetSim similarities did not show significant p-values. A
representative disease of the second group was lipid
storage disease (DOID: 9455). 5 out of the 6 disease
pairs between lipid storage disease and other diseases in
the benchmark set were incorrectly identified, e.g., lipid
storage disease & obesity (DOID: 9970), lipid storage
disease & diabetes mellitus (DOID: 9351) (Table 1). The
number of associated genes of obesity and diabetes mel-
litus was 1,527 and 1,134, respectively. Lipid storage dis-
ease only had 35 associated genes. Out of the 35
associated genes, 15 and 12 genes were shared by obesity
and diabetes mellitus, respectively. Although more than
1/3 associated genes of lipid storage disease appeared in
obesity and diabetes mellitus, they still got a bad NetSim
results. That is because obesity and diabetes mellitus
had a much bigger number of associated genes than lipid
storage disease. This indicates that NetSim performs less
well when two diseases have a large difference in the
number of disease-associated genes. For the random set,
36 out of 700 disease pairs were recognized as related
diseases (false positives). More than half of the 36 dis-
ease pairs were cancer related diseases, e.g., penile neo-
plasm (DOID: 11624) & cecum cancer (DOID: 1521),
pancreatic cancer (DOID: 1793) & tubular adenocarcin-
oma (DOID: 4929) (Table 1). As cancer diseases were
omitted in selecting benchmark set, it is not surprising
that so many disease pairs related to cancers are de-
tected as false positives. The relatedness of diseases
belonging to different top-level DO categories was also
identified, e.g., essential hypertension (DOID: 10825) &
hyperthyroidism (DOID: 7998). Recently, Emokpae et al.
had pointed out that hyperthyroidism was the most
common thyroid disorder observed in patients with es-
sential hypertension [50]. It indicates that our method
can recognize related diseases which apparently seem
unrelated. In addition, the relationship of impulse con-
trol disorder (DOID: 10937) & narcissistic personality
disorder (DOID: 2745) was also detected (Table 1). The
two disease are both in the “disease of mental health”
(DOID: 150) category, but there is no report on their re-
latedness. Therefore, MedNetSim can also discover new
unknown relatedness among diseases.
MedSim can be a useful supplement to function-based
methods
ROC curves of MedSim and other semantic-based
methods based on HPO and DO, respectively, were also
generated (Fig. 5a). For the methods based on HPO,
Lin’s method (HPO_Lin) had the worst performance
with an AUC of only 54.4 %, and Wang et al.’s method
(HPO_wang, 67.3 %) acquired the best performance
among the three methods. As HPO was replaced by DO
to calculate disease similarity, Resnik’s method (64.7 %)
became the worst method, and Wang et al.’s method still
had the best performance with an AUC of 69.2 %. Over-
all, performances of HPO-based methods are similar to
DO-based methods. However, compared to computing
disease similarity based on ontologies, the proposed
MedSim had a significantly better performance than those
methods. MedSim achieved an AUC of 83.5 %, which is
even slightly better than the function-based method BOG.
Figure 5b shows the average AUC for all semantic-based
methods. The result is consistent with Fig. 5a.
Two reasons may explain why MedSim achieved the
best performance among semantic-based methods. On
the one hand, previous methods suffered from the in-
completeness of ontologies and the lack of coverage of
Table 1 Examples of false negatives and false positives with p-values from MedNetSim
Disease 1 Disease 2 P-value (MedSim) P-value (NetSim) P-value (MedNetSim)
False negatives
polycystic ovary syndrome myocardial infarction 0.663 0.004 0.051
lipid storage disease obesity 0.107 0.148 0.070
malaria epilepsy syndrome 0.675 0.016 0.075
lipid storage disease diabetes mellitus 0.108 0.156 0.075
False positives
impulse control disorder narcissistic personality disorder 0.023 0.001 0.002
penile neoplasm cecum cancer 0.023 0.007 0.004
pancreatic cancer tubular adenocarcinoma 0.003 0.107 0.006
essential hypertension hyperthyroidism 0.210 0.021 0.030
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gene-disease or phenotype-disease association data. For ex-
ample, only one-third of DO diseases have associated genes
(see Additional file 1). HPO is widely used in the rare dis-
ease community [51]. However, the infrastructure of
phenotype data for common and infectious diseases [48] is
still developing. On the other hand, MedSim considered
much richer and more diverse information included in lit-
erature, not only disease-related genes, but also disease
symptoms, pathogenesis, therapeutic drugs, and so on.
MedSim requires only biomedical literature, no re-
quirement to know disease-associated gene sets and on-
tologies. It thus has much broader applicability than
previously published methods, especially in the case of
no sufficient gene-disease association data.
The impact of different data sources
Gene-disease association databases
The effectiveness of different gene-disease association
data was evaluated. DisGeNET was used as a replace-
ment for SIDD. Compared to SIDD, DisGeNET has
much more lower reliability associations based on litera-
ture mining. Its disease-gene associations are nearly two
times of those in SIDD, with only 34 % more disease
terms (Fig. 1). Using DisGeNET as gene-disease associ-
ation data source, the AUC of NetSim (called as Net-
Sim_DGN) grew to 96.9 % (Fig. 6a), which is even better
than MedNetSim (AUC: 96.5 %, Fig. 4a) that fused Med-
Sim and NetSim. Integration of MedSim and
NetSim_DGN (MedNetSim_DGN) produced an AUC of
97.5 % (Fig. 6a). Fig. 6b shows the average AUC of Net-
Sim_DGN (96.7 %) and MedNetSim_DGN (97.5 %),
which is consistent with Fig. 6a too. The above observa-
tions show that a richer gene-disease association data,
even with a lower reliability, is favorable for discovering
relatedness between diseases.
Protein interaction datasets
To gauge the impact of different interaction datasets on
computing performance, HumanNet database was used
as the protein interaction network, substituting hPPIN.
The number of protein nodes in HumanNet and hPPIN
do not differ greatly, but the number of interactions in
HumanNet is more than three times that of hPPIN
(Fig. 2). However, the performance of NetSim while
using HumanNet (named as NetSim_HN) did not im-
prove at all compared to using hPPIN, with both achiev-
ing an AUC of 95.1 % (Fig. 6a). Furthermore, the
common interaction pairs of hPPIN and HumanNet (i.e.,
comPPI) were also applied as the protein interaction
network to evaluate the performance of NetSim (Net-
Sim_comPPI, Fig. 6a). Although comPPI had a much
smaller dataset than hPPIN or HumanNet, NetSim_-
comPPI achieved the same performance as NetSim and
NetSim_HN, with an AUC of 95.1 % too. The average
AUC of NetSim_HN and NetSim_comPPI (Fig. 6b) also
showed the same results.
Fig 5 Performance of semantic-based methods. a ROC curves for the experimental results on the benchmark set and a random set. b Average
AUC for the benchmark set and 50 random sets. HPO_Res, HPO_Lin and HPO_Wang denoted disease similarities computation by using Resnik,
Lin and Wang based on HPO, respectively
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Additionally, the average AUC of NetSim with differ-
ent proportions of hPPIN were also computed. As
shown in Fig. 7, the average AUC increased rapidly at
the beginning, it then leveled off and did not grow as
fast once the sampling rate hit 60 %. The average AUC
plateaued at a sampling rate of 80 %. The above results
indicate that merely using more protein interaction data
does not lead to improved performance of NetSim. It
might partially explain why using HumanNet, which has
more than three times protein interaction data than
hPPIN, did not improve the performance of NetSim.
Percentage of interaction pairs sharing GO annotation
was analyzed for HumanNet, hPPIN and their common
protein interactions (comPPI) (Table 2). For the entire
GO annotation and its three categories (GO_BP: bio-
logical process, GO_CC: cellular component, GO_MF:
molecular function), the percentage of pairs sharing an-
notation in hPPIN was higher than that in HumanNet,
suggesting hPPIN has a higher data quality than
HumanNet. The fact that HumanNet did not achieve
improved performance for NetSim may partially be due
to HumanNet’s lower data quality than that of hPPIN. In
addition, whether the entire GO or its three categories,
comPPI had the highest percentage of protein pairs shar-
ing annotation in the three datasets, indicating that
comPPI has the best data quality. The highest data qual-
ity of comPPI may be responsible for it acquiring same
performance as that of hPPIN or HumanNet. All those
results suggest that the quality of protein interaction
data is more important than its volume for the computa-
tion of disease similarity.
Disease similarity network
As shown in Fig. 8, a disease similarity network (DSN)
was generatedty based on MedNetSim from the top-
ranking 0.5 % of pair-wise similarity values among 3,201
Fig 6 The impact of different data sources. a ROC curves for the experimental results on the benchmark set and a random set. b Average AUC
for the benchmark set and 50 random sets
Fig 7 The average AUC of NetSim with different proportion of
hPPIN sampled
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diseases in DO. 2,885 of the 3,201 diseases showed at
least one connection to another disease, and 25,607
edges were formed between those diseases (Additional
file 5). Each node in the network represented a disease.
Those nodes belonged to 14 top-level DO categories and
were colored according to their corresponding DO cat-
egories, such as “respiratory system disease” (DOID:
1579), “metabolic disease” (DOID: 0014667), “infectious
disease” (DOID: 0050117), and so on. DO classified
diseases both by anatomical site or system, and by gen-
eral pathology. For each of the classifications, despite
these different criteria, diseases within one category were
usually in close proximity to each other (Fig. 8), such as
“disease of cellular proliferation” (DOID: 14566), “dis-
ease of mental health” (DOID: 150), “nervous system
disease” (DOID: 863), and so on.
MedNetSim can also identify related disease groups
belonging to different DO category. One example of
these is myasthenia gravis (DOID: 437) which belongs to
the “nervous system disease” (DOID: 863) category.
Figure 9a showed the sub-network around myasthenia
gravis (MG). It is not surprised that we found MG was
related with “immune system disease” (DOID: 2914). Ac-
tually, MG is associated with various autoimmune dis-
eases, including thyroid diseases [52] and lupus [53].
Thymoma (DOID: 3275) was found as the strongest as-
sociated partner of MG with a MedNetSim similarity up
Table 2 Percentage of interaction pairs sharing GO annotation
GO GO_BP GO_CC GO_MF
HumanNet 75.30 % 28.33 % 56.75 % 52.82 %
hPPIN 89.28 % 38.52 % 71.96 % 73.94 %
comPPIa 95.15 % 59.36 % 82.10 % 81.65 %
GO Gene Ontology, GO_BP biological process, GO_CC cellular component,
GO_MF molecular function
aThe common protein-protein interactions between HumanNet and hPPIN
Fig 8 An overview of disease similarity network (DSN) based on MedNetSim results. The graph was based on a force-directed layout using the
similarity between diseases as attraction force. Nodes were colored according to the top-level DO category to which they belong
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to 0.181 (p-value = 1.21 × 10−4), and vice versa. The rela-
tionship between thymic abnormalities and MG had also
been reported [54]. Additionaly, MedNetSim can also be
used to recognize new relatedness between diseases.
Fibromyalgia (DOID: 631), belonging to the “musculo-
skeletal system disease” (DOID: 17) category, was taken
as an example. As shown in Fig. 9b, fibromyalgia was as-
sociated to several mental health diseases, e.g., pain dis-
order (DOID: 0060164), postpartum depression (DOID:
9478). Studies has shown that fibromyalgia is frequently
associated with depression and chronic pain [55]. There
were a few reports on the relatedness between fibro-
myalgia and personality disorder (DOID: 1510) [56, 57].
However, fibromyalgia’s relationship with antisocial per-
sonality disorder (DOID: 10939) and avoidant personal-
ity disorder (DOID: 1509) are currently not reported.
Interestingly, their associations were found in Fig. 9b. It
was also found that melancholia (DOID: 2848) was re-
lated to fibromyalgia. Those new found relatedness be-
tween diseases might deserve further research to
understand their common pathophysiology and help
drug repositioning research.
Conclusions
Methods based on protein interaction networks, litera-
ture data (MEDLINE), and their integration, were devel-
oped to compute disease similarity (NetSim, MedSim
and MedNetSim). Taking advantage of the entire protein
interaction network, NetSim obtained the best perform-
ance in all function-based methods. Among semantic-
based methods, the performance of MedSim achieved
significantly better results. MedSim does not require
prior knowledge of disease-associated genes, enabling it
to have a wider range of application than the other
methods. MedSim can be a great supplement to
function-based algorithms, especially when there is not
enough gene-disease association data. The further im-
proved AUC of MedNetSim shows that integrating bio-
medical literature and protein interaction data can be an
effective way to improve computation for disease
similarities.
Quality of protein interaction data was found to be
more important than its volume, while higher volume of
gene-disease association data, even with lower reliability,
is more beneficial for disease similarity computation. In
a situation of limited resources, it maybe beneficial to
put more efforts toward obtaining more gene-disease as-
sociation data and improving the quality of protein-
protein interaction network.
MedSim, NetSim and MedNetSim are availalbe at
http://www.digintelli.com:8000/. The user can enter two
diseases of interest; the web service will compute their
similarity and present a corresponding p-value.
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